Author Question: Which of the following statements is true regarding the latent conflict stage of Pondy's model of ... (Read 77 times)

armygirl

  • Hero Member
  • *****
  • Posts: 556
Which of the following statements is true regarding the latent conflict stage of Pondy's model of organizational conflict?
 
  A) During this stage there exists a potential for conflict.
  B) The stage of manifest conflict comes immediately after this stage.
  C) Fighting and open aggression are common during this stage.
  D) This stage comes immediately after the stage of felt conflict.

Question 2

In an organization, people in line functions view themselves as the critical organizational resource and people in staff functions as secondary players.
 
  Acting on this belief, the line function constantly uses its supposedly lofty status as the producer of goods and services to justify putting its interests ahead of the other functions' interests. Based on this information, the organization is at which stage of Pondy's model of organizational conflict?
  A) manifest conflict
  B) conflict aftermath
  C) felt conflict
  D) latent conflict



sabina576

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

Props to you, cheers.

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Most women experience menopause in their 50s. However, in 1994, an Italian woman gave birth to a baby boy when she was 61 years old.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library